Provenance Biopharmaceuticals Corp.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Provenance Biopharmaceuticals Corp.
Partnership will combine AbCellera’s screening of antibodies to the virus with Lilly’s development, commercial capabilities. Vir adds Biogen tie-up to its ongoing coronavirus efforts.
Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.